Moneycontrol
YOU ARE HERE > Moneycontrol > Mutual Funds > Evaluate > Performance Tracker : Sector - Pharma & Healthcare
Performance Tracker

Sector - Pharma & Healthcare

Funds with an investment objective to invest in pharmaceutical, healthcare and related sectors.
Sector - Pharma & Healthcare - Returns (in %) - as on Nov 20, 2017
Compare With Indices
  • Sensex
  • Nifty
  • BANK Nifty
  • BANKEX
  • BSE Auto
  • BSE CD INDEX
  • BSE FMCG INDEX
  • BSE HEALTHCARE
  • BSE IPO
  • BSE IT INDEX
  • BSE Metal
  • BSE Oil & Gas
  • BSE POWER INDEX
  • BSE PSU INDEX
  • BSE REALTY
  • BSE TECk INDEX
  • BSE-100
  • BSE-200
  • BSE-500
  • BSE-MIDCAP
  • BSE-SMALLCAP
  • CAPITAL GOODS
  • CNX 100
  • CNX IT
  • CNX Midcap
  • CNX NIFTY JR
  • Nifty Midcap 50
  • S&P CNX 500
  • S&P CNX Defty

Mutual Fund Scheme

Crisil Rank AUM
(Rs. cr.)
Sep 17
1mth 3mth 6mth 1yr 2yr 3yr 5yr  
* Returns over 1 year are Annualised
Sponsored Advt.
Reliance Pharma Fund (G) Not Ranked
1,300.33 1.5 11.5 5.7 -2.6 -4.0 2.9 15.8
Reliance Pharma Fund - Direct (G) Not Ranked
164.86 1.6 11.8 6.2 -1.7 -3.2 3.8 --
UTI Pharma & Health - Direct (G) Not Ranked
25.68 0.2 6.7 0.3 -2.7 -3.6 1.1 --
Reliance Pharma Fund (G) Not Ranked
1,300.33 1.5 11.5 5.7 -2.6 -4.0 2.9 15.8
UTI Pharma & Health (G) Not Ranked
294.80 0.1 6.4 -0.2 -3.6 -4.5 0.2 13.9
Tata India Pharma & HealthCare -Dir (G) Not Ranked
12.66 -0.7 6.2 -5.5 -4.4 -- -- --
SBI Pharma Fund - Direct (G) Not Ranked
188.86 0.2 6.8 -0.1 -5.5 -5.5 3.7 --
Tata India Pharma & HealthCare - RP (G) Not Ranked
76.44 -0.9 5.8 -6.2 -6.0 -- -- --
SBI Pharma Fund (G) Not Ranked
795.12 0.1 6.5 -0.7 -6.6 -6.7 2.5 17.4
CATEGORY AVERAGE -0.7 5.8 -2.3 -3.8 -4.0 1.4 11.5

Note : Returns have been calculated based on NAV's as on Nov 20, 2017 & Index values as on Nov 20, 2017

As per AMFI guidelines, effective from quarter ending December 31, 2010, fund houses have stopped publishing the Assets Under Management (AUM) on a monthly basis. This data is published every quarter.

Quick Links (Mouseover on for more information)
Sections
Follow us on
Available On